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Background: Several studies have shown effects of current and maternal smoking 
during pregnancy on DNA methylation of CpG sites in newborns and later in life. Here, we 
hypothesized that there are long-term and persistent epigenetic effects following maternal 
smoking during pregnancy on adolescent offspring DNA methylation, independent 
of paternal and postnatal smoke exposure. Furthermore, we explored the association 
between DNA methylation and cardiometabolic risk factors at 17 years of age.
Materials and Methods: DNA methylation was measured using the Illumina 
HumanMethylation450K BeadChip in whole blood from 995 participants attending 
the 17-year follow-up of the Raine Study. Linear mixed effects models were used to 
identify differential methylated CpGs, adjusting for parental smoking during pregnancy, 
and paternal, passive, and adolescent smoke exposure. Additional models examined the 
association between DNA methylation and paternal, adolescent, and passive smoking 
over the life course. Offspring CpGs identified were analyzed against cardiometabolic risk 
factors (blood pressure, triacylglycerols (TG), high-density lipoproteins cholesterol (HDL-
C), and body mass index).
Results: We identified 23 CpGs (genome-wide p level: 1.06 × 10−7) that were 
associated with maternal smoking during pregnancy, including associated genes AHRR 
(cancer development), FTO (obesity), CNTNAP2 (developmental processes), CYP1A1 
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INTRODUCTION
Maternal smoking during pregnancy is associated with an 
increased risk in the offspring of chronic diseases including 
asthma, certain cancers, and cardiovascular disease in adulthood 
(Wakschlag et al., 2002; Hofhuis et al., 2003; DiFranza et al., 2004; 
Oken et al., 2005; Agrawal et al., 2010; Bhattacharya et al., 2014). 
Together with the association of antenatal exposure to maternal 
smoking with DNA methylation, this highlights the importance of 
the early environment on the development of diseases (Gillman, 
2005; Hanson and Gluckman, 2008; Schulz, 2010; Nielsen et al., 
2016). Furthermore, associations with maternal smoking during 
pregnancy have been associated with differential methylation 
of cytosine–phosphate–guanine (CpG) base pairs in newborns 
(Joubert et al., 2016), children (Rzehak et al., 2016), young adults 
(Lee et al., 2015), and middle aged adults (Sun et al., 2013).
An epigenome-wide DNA methylation meta-analysis by 
Joubert et al. with combined sample size of 6,685 newborns and 
3,187 older children previously identified 2,965 methylated CpGs 
in the offspring that associated with maternal smoking during 
pregnancy (Joubert et al., 2016). Methylation levels at CpGs 
most strongly associated with maternal smoking were contained 
within genes also implicated in other studies including MYO1G 
(myosin 1G), CYP1A1 (cytochrome P450 family 1 subfamily A 
member 1), GFI1 (growth factor independent 1 transcriptional 
repressor), CNTNAP2 (contactin-associated protein-like 2) 
(Rotroff et al., 2016; Rzehak et al., 2016; Tehranifar et al., 2018), 
and xenobiotics (AHRR, aryl-hydrocarbon receptor repressor) 
(Finkelstein and Jeong, 2017). These genes have been associated 
with tumorigenesis and metastasis (in the case of MYO1G, 
CTNAP2, GFI1, and AHRR), activation of compounds with 
carcinogenic properties (in the case of CYP1A1 and AHRR), and 
autism (CNTNAP2), as well as mediating the effect of maternal 
smoking and birthweight (in the case of GFI1) (Finkelstein, 
2017), thereby suggesting a possible epigenetic mechanism 
linking exposure to smoking during pregnancy with adverse 
outcomes such as obesity or cancer risk in the offspring.
Several studies have focused on the effect of current 
smoking on CpG methylation in adults and conclude that it 
strongly affects DNA methylation within the genes of AHRR, 
GFI1, and MYO1G and mediates risk of disease (Su et al., 
2016; Bojesen et al., 2017; Wilson et al., 2017; Li et al., 2018). 
However, the studies did not account for the influence of 
maternal smoking during pregnancy (Wilson et al., 2017; Li 
et al., 2018). The overlap of CpGs sites that associate with both 
current (adolescent or adult) smoking and maternal smoking 
during pregnancy indicates the need for caution in attributing 
causation to postnatal smoke exposure (Lee et al., 2015; Joubert 
et al., 2016; Rzehak et al., 2016). Richmond et al. (2015) for 
example showed associations between maternal smoking during 
pregnancy and CpG methylation measured at three different 
timepoints. In utero smoke exposure was associated with CpGs 
within AHRR, MYO1G, CYP1A1, and CNTNAP2 independent 
of current smoking of the adolescents. Furthermore, a recent 
study in 40-year-old women showed associations between 
CpG methylation levels in FTO (fat mass and obesity-
associated protein), CYP1A1, MYO1G, AHRR, ANPEP (alanyl 
aminopeptidase, membrane), ZNF536 (zinc finger protein 536), 
and GFI1 and a history of exposure to maternal smoking in 
utero, which was independent of their own smoking status 
(Tehranifar et al., 2018). Socioeconomic status is potentially 
an important confounder in the association between CpG 
methylation and offspring smoking. Low socioeconomic status 
has, for example, been associated with both smoking in general 
(Rosemary et al., 2012) and offspring smoking (Gilman et al., 
2003) and DNA methylation levels (McDade et al., 2019).
(detoxification), MYO1G (cell signalling), and FRMD4A (nicotine dependence). A sensitivity 
analysis showed a dose-dependent relationship between maternal smoking and offspring 
methylation. These results changed little following adjustment for paternal, passive, or 
offspring smoking, and there were no CpGs identified that associated with these variables. 
Two of the 23 identified CpGs [cg00253568 (FTO) and cg00213123 (CYP1A1)] were 
associated with either TG (male and female), diastolic blood pressure (female only), or 
HDL-C (male only), after Bonferroni correction.
Discussion: This study demonstrates a critical timing of cigarette smoke exposure over 
the life course for establishing persistent changes in DNA methylation into adolescence 
in a dose-dependent manner. There were significant associations between offspring 
CpG methylation and adolescent cardiovascular risk factors, namely, TG, HDL-C, and 
diastolic blood pressure. Future studies on current smoking habits and DNA methylation 
should consider the importance of maternal smoking during pregnancy and explore 
how the persistent DNA methylation effects of in utero smoke exposure increase 
cardiometabolic risk.
Keywords: DNA methylation, maternal smoking during pregnancy, epigenetics, Raine Study, cardiometabolic 
health, adolescence
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A recent study analyzed the association between eight CpGs, 
located in the GFI1 gene region and cardiovascular health (Parmar 
et al., 2018). The authors found three out of the eight CpGs to be 
associated with maternal prenatal smoking and the remaining 
five to be associated with adolescents own smoking. They found 
the strongest associations between some of the CpGs with BMI, 
waist circumference, blood pressure, and triacylglycerol (TG), 
with the most consistent associations between CpGs and TG. 
This highlights the potential for maternal smoking to induce long 
lasting changes in association with both DNA methylation and 
cardiometabolic health.
The present study aimed to investigate whether there is 
an association between maternal smoking during pregnancy 
and DNA methylation in the offspring at 17 years of age and 
if methylation levels at the differentially methylated CpGs 
were associated with cardiometabolic risk factors, using data 
from the second generation (Gen2) of the Raine Study (www.
rainestudy.org.au). We further determined if the relationships 
between methylation levels at these particular CpGs and 
maternal smoking were independent of paternal smoking, 
passive smoke exposure during childhood, and adolescent self-
reported smoking. We hypothesized that there are long-term 
and persistent postnatal epigenetic effects following maternal 
smoking during pregnancy on adolescent offspring DNA 
methylation, relatively unaffected by smoke exposure from 
other sources. Furthermore, we hypothesize that these changes 
are associated with an adverse effect on cardiometabolic health.
METHODS
Study
The study design and initial characteristics of the Raine Study 
have been previously described (Newnham et al., 1993). From 
1989 to 1999, a total of 2,900 pregnant women were enrolled to 
take part in this longitudinal cohort study. Recruitment took 
part at King Edward Memorial Hospital and surrounding private 
hospitals. The 2,868 live births (Gen2) have been followed up at 
1, 2, 3, 5, 8, 10, 14, and 17 years during which anthropometric 
(e.g., height, weight, skinfolds), clinical, and biochemical data 
have been collected.
Ethics approval for conducting the epigenetic analysis at the 
17-year follow-up was given by the Human Ethics Committee of 
the University of Western Australia. Informed and written consent 
was provided by the participants and their parents or carer.
The present analyses included 790 participants that had data 
for the variables of interest, being maternal educational level, 
family income, gestational weight gain, gestational age, maternal 
age, maternal prepregnancy BMI, birthweight, age, Caucasian 
ethnicity, and sex of the child. In separate analyses, we examined 
the potential confounding effects of offspring smoking (n = 663), 
passive smoking (n = 513), and paternal smoking (n = 781).
Smoking Variables
Maternal self-reported smoking during the 18th and 34th 
week of gestation and paternal smoking behavior (reported 
by the mother) at the 18th week of gestation were obtained by 
questionnaire. Smoking behavior of the adolescents at 17 years 
of age was self-reported in a confidential online questionnaire. 
Adolescents self-reported cigarette consumption over their 
lifetime (yes/no), in the past month (yes/no), and past 7 days (yes/
no). Different smoking variables were derived for the analyses: 
Maternal smoking during pregnancy was coded as “never” versus 
“ever” smoking during pregnancy, based on the categorical 
variables for the number of cigarettes smoked daily at 18 and 34 
weeks of gestation. Furthermore, maternal smoking at 18 and 34 
weeks of gestation was analyzed in association with CpG in two 
separate statistical models, to ascertain if smoking during mid- or 
late-term pregnancy had a different effect on CpG methylation 
in the offspring. Smoking of the offspring was coded as a binary 
variable (“never” vs. “ever” smoked). Passive smoking exposure 
during childhood was defined by aggregating questionnaire data 
from the caregiver on smoking at eight intervening time points 
until 17 years (1, 2, 3, 5, 8, 10, 14, and 17) and coded as “never” 
versus “ever” exposed to passive smoking if the average number of 
cigarettes smoked over all time points was ≥1 (Le-Ha et al., 2013).
Cardiovascular and Anthropometric 
Variables
Height was measured using a stadiometer (Holtain, Crosswell, 
UK) to the nearest 0.1 cm. Weight was measured using a digital 
chair scale (Wedderburn, New South Wales, Australia) to the 
nearest 100 g. Body mass index (BMI) was calculated as weight 
(kilograms)/height (meters)2. Waist circumference was measured 
to the nearest centimeter.
Venous blood samples were taken after an overnight fast. 
Serum insulin, glucose, high-density lipoprotein cholesterol 
(HDL-C), low-density lipoprotein cholesterol (LDL-C), and 
triacylglycerols (TG) were measured in the PathWest Laboratory 
at Royal Perth Hospital as described (Huang et al., 2012). 
HOMA-IR (molar units) was calculated by insulin (mIU/L) × 
glucose (mmol/l)/22.5 (Matthews et al., 1985).
Laboratory Measures
DNA Methylation Profiling
Using whole-blood samples collected at age 17 years, epigenome-
wide DNA methylation profiles for 1,192 (58 technical replicates) 
individuals were generated at the Centre for Molecular Medicine 
and Therapeutics, University of British Columbia using the 
Illumina Infinium HumanMethylation450 BeadChip array 
(Illumina San Diego, CA). Quality control was performed using 
the statistical software R and Bioconductor packages shinyMethyl 
(Fortin et al., 2014), MethylAid (Van Iterson et al., 2014), and 
RnBeads (Assenov et al., 2014).
Four participants with inconsistent results and identified as 
outliers (n = 3) or sex misclassification (n = 1) were removed. 
Sixty-five CpGs for which a common SNP disrupted the site 
leading to genotypic specific methylation levels, 11,648 sex 
chromosome CpGs and 10,777 CpGs with a detection p > 0.05 
in any sample were removed. A further 160 probes with bead 
counts <3 in more than 5% of samples were removed. Batch effects 
persisted after beta-mixture quantile normalization (BMIQ) was 
applied (Teschendorff et al., 2013). Therefore, plate, slide, and 
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well number were included in all statistical models. As cellular 
heterogeneity can influence methylation profiles and drive some 
of the methylation differences detectable across individual blood 
samples, we adjusted for estimated cell counts using the Houseman 
estimating method (Houseman et al., 2014) as implemented in 
the R statistical package, minfi (Aryee et al., 2014) for six cell 
types (CD8T, CD4T, NK, B cell, monocytes, and granulocytes). 
Mapping of the CpG to the nearest gene was performed using the 
Illumina Infinium annotation genomic coordinates.
Genome-Wide Genotype Data
DNA was collected from blood samples from 74% of the 
adolescents who attended the 14-year follow-up and a further 
5% who attended the 16-year follow-up, using standardized 
procedures. SNP data for this study were obtained from genome-
wide genotype data as described previously (Jones et al., 2013). 
Briefly, genotyping was performed on the Illumina Human 
660W Quad Array (Illumina, San Diego, California, USA), and 
exclusion criteria were low genotyping success (>3% missing), 
excessive heterozygosity, relation with another sample (identity 
by descent > 0.1875), ambiguous sex, and mislabeling. There 
were 1,494 individuals whose DNA samples passed the quality 
control criteria and were eligible for genetic analyses, and 965 
of them had completed the AQ. Out of those, 753 samples 
overlapped with the 790 samples that had epigenetic information 
and nonmissing data in the covariates.
Statistical Analysis
All models were analyzed using R Version 3.4.3. A flow diagram 
of models and sample size is presented in Figure 1, showing the 
different analysis steps and the number of complete cases per 
analysis. Full results are presented in the Supplemental Tables.
Effect Modifier
Studies previously conducted to analyze the association 
between maternal smoking during pregnancy and offspring 
CpG methylation levels have controlled for a variety of effect 
modifiers with a high level of commonalities between studies. 
Potential maternal confounders included prepregnancy BMI and 
socioeconomic variables including family income and maternal 
education, gestational weight gain, maternal alcohol consumption 
during pregnancy, and maternal age. Offspring variables included 
birthweight, sex, and age. Analyses were adjusted for cell count 
using the reference-based Houseman approach (Sun et al., 2013), 
for batch effect and measurement derived variability utilizing 
linear mixed effect models with plate number as the random 
effect and the aforementioned variables. Hypothesis testing 
for differences between the maternal smoking exposed and 
the nonexposed group in the variables used in this study were 
performed using chi-squared tests for categorical and t-tests and 
Wilcoxon tests for continuous variables.
Models
Identification of CpGs Whose Methylation Levels Associated 
With Maternal Smoking
We used a linear mixed-effects model as our main model. The 
outcome was percent methylation at one single CpG per model, 
and the predictor was maternal smoking, adjusted for exact age 
of the adolescent, sex, and maternal, and offspring confounders 
as described previously (n = 790). The same model was run twice, 
with the second application also adjusted for blood cell count 
FIGURE 1 | Flow diagram of the analysis and sample size per model.
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estimate (Houseman et al., 2014). This stepwise approach ensures 
that differences in the adjustment for cell count are accessible. 
To account for multiple testing, we utilized a conservative 
Bonferroni approach (genome-wide p level: 1.06 × 10−7).
The main model with maternal smoking was then assessed for 
a sex interaction to examine if the effect of maternal smoking on 
the CpG methylation levels differed between male and female.
Additionally, we used the information on maternal average 
cigarette consumption during pregnancy (six categories: none, 
1–5 daily; 6–10 daily; 11–15 daily; 16–20 daily; and 31 or more, 
with none as the reference group) to test for dose-dependent 
methylation in the identified sites.
Assessing the Effect of Paternal, Passive, and Adolescent 
Smoking on DNA Methylation
We included the covariates “ever smoking at 17 years of age” (yes/
no) (n = 663), paternal smoking during pregnancy (n = 781) and 
passive smoking exposure during childhood (n = 513) (Le-Ha 
et al., 2013) to the main model predicting the CpGs associated 
with maternal smoking, to ascertain if they changed the effect 
size of maternal smoking. We also examined the effect of those 
variables in separate models as predictors.
For adolescent smokers, we split the data into those who were 
exposed to maternal smoking during pregnancy (n = 168) and 
those who were not exposed (n = 495) to explore any potential 
differences in effect sizes. The model was the same as described 
above, including confounders as described earlier.
Assessing the Genetic Effect on the Association Between 
Maternal Smoking and CpG Methylation
To assess if the association between maternal smoking and CpG 
methylation persists after taking SNPs into account, we utilized 
the GEM bioconductor package (Pan et al., 2016) to identify 
significant SNP–CpG associations in the Raine study. The 
GEM package is a computational efficient approach to identify 
methylation quantitative trait loci, perform DNA-methylation 
wide association studies, and assess the interaction of CpG 
methylation and SNPs on outcomes.
With GEM, those SNPs were identified, which were 
significantly associated with the CpGs associated with maternal 
smoking during pregnancy in this study. The identified SNPs 
were added to the respective main model with CpG as outcome 
and maternal smoking during pregnancy as predictor, adjusted 
for the aforementioned variables.
RESULTS
Characteristics of the Population
The characteristics of the participants are shown in Table 1. Of the 
995 Caucasian participants, 30% were exposed to maternal smoking 
during pregnancy. Paternal, passive, and adolescent smoking rates 
were higher in the group exposed to maternal smoking. Of those 
exposed to maternal smoking during pregnancy, 60% had fathers 
who also smoked during the pregnancy period, 41% were exposed 
to passive smoking, and 30% reported smoking themselves. Of 
those not exposed to maternal smoking, 24% had fathers who 
smoked during the pregnancy period, 25% were exposed to passive 
smoking, and 40% reported smoking themselves.
TABLE 1 | Characteristics of the participants of the Raine Study. The p value 
refers to chi-square test results for categorical and t-test/Wilcoxon test for 
continuous variables.
No maternal 
smoking
Maternal 
smoking
p value
N 699 296
ADOLESCENT CHARACTERISTICS 
Sex of the child [n(%)]  0.17
 Female 337 (48.21) 157 (53.04)
 Male 362 (51.79) 139 (46.96)
Adolescent age  0.133
 Mean 17.24 17.29
 SD 0.58 0.61
Birthweight  2.09E−11
 Mean 3,430.85 3,137.17
 SD 526.64 657.46
Corrected gestational age 
(days)
 0.00071
 Mean 276.59 272.52
 SD 12.18 19.31
Waist circumference (cm)  0.039
 Mean 79.03 81.15
 SD 11.11 12.55
Adolescent BMI (kg/m²)  0.001
 Mean 22.8 24.12
 SD 4.16 5.19
Adolescent HDL-C (mg/dl)  0.03337
 Mean 1.3 1.27
 SD 0.29 0.3
Adolescent LDL-C (mg/dl)  0.35
 Mean 2.33 2.38
 SD 0.66 0.71
Adolescent triacylglycerol 
(mg/dl)
 0.012
 Mean 1.04 1.15
 SD 0.5 0.67
Adolescent systolic blood 
pressure (mmHg)
 0.3247
 Mean 114.99 115.69
 SD 11.37 10.73
Adolescent diastolic blood 
pressure (mmHg)
 0.6639
 Mean 59.43 59.6
 SD 6.56 6.78
Adolescent HOMA-IR  0.1503
 Mean 2.04 2.11
 SD 2.85 1.82
SMOKE EXPOSURE DURING
OTHER PERIODS OF LIFE
Paternal smoking during 
pregnancy [n(%)]
  <2.2E−16
 No 519 (74.25) 113 (38.18)
 Yes 174 (24.89) 178 (60.135)
 Missing 6 (0.86) 5 (1.69)
Passive smoking [n(%)]   <2.2E−16
 No 292 (41.77) 20 (6.76)
 Yes 134 (19.17) 122 (41.22)
 Missing 273 (39.06) 154 (52.03)
Adolescent smoking  0.002541
 Yes 381 (54.51) 119 (40.20)
 No 158 (22.60) 75 (25.34)
 Missing 160 (22.89) 102 (34.46)
(Continued)
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Offspring exposed to maternal smoking during pregnancy 
included 49% from families in the lowest income bracket 
compared with 29% of those not exposed to maternal smoking. 
The group exposed to maternal smoking during pregnancy had 
significantly more mothers with a lower educational attainment 
(p < 0.001). Mothers who smoked during pregnancy were 
younger (26.76 ± 5.63 vs. 29.17 ± 5.8 years old) than those who 
did not smoke.
Those exposed to maternal smoking had significantly higher 
waist circumference (p = 0.039), BMI, and TG and lower HDL-C 
at 17 years of age compared to the nonexposed group.
For all smoking variables, those study participants of the original 
cohort who are not included in this study (n = 1,317) had higher 
numbers of smokers and smoke exposed individuals as well as lower 
socioeconomic status assessed by family income compared to the 
participants included in our study [n = 995 (Supplement Table S1)].
Epigenome-Wide DNA Methylation Analysis
Effects of Maternal Smoking on Offspring DNA 
Methylation
One identified CpG, namely, cg04224247 (WWC3), showed 
a bimodal distribution in the histogram, suggestive of a 
genotype driven rather than an environmental influence (Teh 
et al., 2014) and hence was excluded from further analysis.
Associations between any maternal smoking during pregnancy 
and methylation levels at individual CpG sites are shown in a forest 
plot (Figure 2). The analysis showed that inclusion or exclusion 
of cell count estimation based on the Houseman method did 
not change the number of CpGs whose methylation levels were 
associated with maternal smoking after Bonferroni correction 
(genome-wide p level: 1.06 × 10−7, Supplemental Tables S2, S3, 
and S4). The smoking variables that combined data from 18 and 
34 weeks did not differ in the direction of their association with 
CpGs in that methylation at the same CpGs was associated with 
maternal smoking at i) 18 weeks, ii) 34 weeks, and iii) combined 
18 or 34 weeks (Supplemental Tables S1, S5, and S6).
The final model, including all confounding variables and 
batch number as random effect, showed methylation levels at 
23 CpGs associated with maternal smoking during pregnancy 
after conservative Bonferroni correction; these 23 CpGs mapped 
to 10 genes (Table 2). Overall, seven CpGs (genes: CNTNAP2, 
GFI1, WWC3, AHRR, and APOB) showed hypomethylation 
in association with mothers who reported they were smoking 
during pregnancy, whereas 16 CpGs (associated genes: CYP1A1/
CYP1A2, MIR548T, AHRR, FRMD4A, FTO, and MYO1G) 
were hypermethylated in those whose mothers smoked during 
pregnancy compared to offspring of nonsmokers. The highest 
percentage difference in DNA methylation between maternal 
smoking categories was 8.3% at cg12803068 (mapped to 
MYO1G). The remainder of the top 23 CpGs show methylation 
changes in association with in utero smoke exposure in the range 
of 1–6% (Table 2, coefficient times 100).
Inclusion or exclusion of cell count estimation in the model 
did not change either the number or direction of association 
CpGs falling under the Bonferroni threshold (genome-wide 
p  level: 1.06 × 10−7, Supplemental Tables S2 and S3).
Dose Dependency With Maternal Smoking:  
Sensitivity Analysis
A sensitivity analysis for dose-dependent methylation with 
maternal smoking showed a significant trend towards hyper- 
or hypomethylation with an increasing number in cigarettes 
consumed (Wilcoxon significance test between groups p < 0.05). 
These results can be seen in the supplement (Supplemental 
Figure 1).
Effect of Other Sources of Smoke Exposure on 
Offspring DNA Methylation
Adjusting the main maternal smoking model for all additional 
smoking variables reduced the sample size due to missing values 
in the offspring self-reported smoking to 506 but did not change 
the direction of the estimates, as can be seen in the forest plot, 
comparing the models by beta coefficients (Supplemental 
Figure 2 and Supplemental Table S7). Methylation levels at four 
CpGs (cg04180046, cg12803068, cg25949550, and cg05549655) 
were still significantly associated with maternal smoking 
(Supplemental Table S6 and S7). These were also the most 
significant CpGs in the main model.
TABLE 1 | Continued
No maternal 
smoking
Maternal 
smoking
p value
N 699 296
MATERNAL AND FAMILIAL
CHARACTERISTICS 
Maternal alcohol 
consumption during 
pregnancy [n(%)]
 0.4107
 no 354 (50.64) 147 (49.66)
 yes 344 (49.21) 149 (50.34)
 missing 1 (0.14)
Maternal school level 
[n(%)]
 1.65E−11
 None 292 (41.77) 182 (61.49)
  Trade certificate or 
apprenticeship
55 (7.87) 27 (9.12)
  Professional registration 
(nondegree)
90 (12.88) 22 (7.43)
 College diploma or degree 129 (18.45) 40 (13.51)
 University degree 102 (14.59) 10 (3.38)
 Other 31 (4.43) 15 (5.07)
Family income [n(%)]  2.91E-06
 <24,000 AUD per annum 206 (29.47) 127 (42.91)
 >24,000 AUD per annum 475 (67.95) 148 (50)
 NA 18 (2.58) 21 (7.09)
Maternal age (years)  1.62E−12
 Mean 29.17 26.76
 SD 5.8 5.63
Maternal prepregnancy 
BMI (kg/m²)
 0.3591
 Mean 22.66 22.25
 SD 4.45 4.51
Maternal pregnancy 
weight gain ratio
 0.9944
 Mean 0.5 0.5
 SD 0.2 0.21
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Stratified analysis for methylation levels at the identified 23 
CpGs for male and female did not show significant effect size 
changes compared to the full model (Supplemental Figure 3). 
Furthermore, Supplemental Figure 4 shows a barplot comparing 
the methylation change between those not exposed to any 
smoking (n = 381), those only smoking at 17 years (n = 158), 
those only exposed to maternal smoking during pregnancy (n = 
119), and those exposed to both types of smoking (n = 75).
Effect of Paternal Smoking During Pregnancy
Paternal smoking (yes/no) during pregnancy (n = 692) was not 
significantly associated with methylation levels at any of the 23 
CpGs detected in the maternal smoking EWAS (all genome-
wide p > 1.06 × 10−7, Supplemental Table S8). Adding paternal 
smoking to the main model did not change the effect size for the 
effect of maternal smoking on CpG methylation levels. An EWAS 
of paternal smoke exposure did not detect any associations with 
CpG methylation levels at the genome-wide significance p < 
1.06 × 10−7 (Supplemental Table S8).
Effect of Childhood Exposure to Smoking
No significant associations were detected for passive smoke 
exposure of the adolescent (n = 530) (Le-Ha et al., 2013) with 
DNA methylation at any CpG (all genome-wide p > 1.06 × 10−7) 
(Table 2, Supplemental Table S9). Adding passive childhood 
exposure to the main model did not change the effect size for 
the effect of maternal smoking on CpG methylation levels. An 
EWAS of passive smoke exposure did not show any associations 
with CpG methylation levels at the genome-wide significance p < 
1.06 × 10−7 (Supplemental Table S9).
Effect of Adolescent Smoking
Adolescent reported smoking behavior (yes/no, n = 663) was not 
associated with the methylation level of any of the 23 CpGs detected 
in the maternal smoking EWAS (full results of the adolescent 
smoking EWAS: Supplemental Table S10). The p  values, effect 
sizes and standard errors are reported in Table 2. Adding active 
adolescent smoking to the main model did not change the effect 
size for the effect of maternal smoking on CpG methylation. An 
FIGURE 2 | Forrest plot for the epigenome-wide association study with maternal smoking as predictor and individual CpG sites as outcome, adjusted for sex, offspring 
age, age of the mother, birthweight, gestational weight gain, maternal alcohol consumption during pregnancy, maternal school level, maternal prepregnancy BMI, family 
income during pregnancy, cell count, and batch effects. Stratified by models without further adjustment (n = 790), adjustment for paternal smoking (n = 692), passive 
smoking (n = 530), and adolescent smoking (n = 663). X-axis: effect size from the linear mixed effects model and confidence interval; Y-axis: individual CpGs.
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TABLE 2 | CpGs associated with maternal smoking during pregnancy with UCSC gene annotation and model p-values, beta-coefficients and standard errors from the epigenome wide association study. The 
Bonferroni significance threshold is 1.06 × 10–7.
Chromosome ID Function Gene Location UCSC_CpG_Islands_Name Relation_to_
UCSC_CpG_
Island
P.Value Coefficient Standard 
Error
7 cg04180046 intronic MYO1G Body chr7:45002111-45002845 Island 8.93E-31 0.059451122 0.004899729
7 cg12803068 intronic MYO1G Body chr7:45002111-45002845 S_Shore 1.04E-22 0.083162901 0.008174077
15 cg05549655 intergenic CYP1A1,CYP1A2 TSS1500 chr15:75018186-75019336 Island 5.83E-19 0.032945838 0.003593891
7 cg25949550 intronic CNTNAP2 Body chr7:145813030-145814084 S_Shore 1.39E-18 –0.013562513 0.001496779
7 cg22132788 exonic MYO1G Body chr7:45002111-45002845 Island 5.43E-17 0.043777558 0.005088082
7 cg19089201 UTR3 MYO1G 3’UTR chr7:45002111-45002845 Island 2.76E-15 0.040922837 0.005057333
1 cg14179389 intronic GFI1 Body chr1:92945907-92952609 Island 1.53E-14 –0.032050625 0.004077831
7 cg11207515 intronic CNTNAP2 Body 3.80E-13 –0.033065175 0.004462166
15 cg13570656 intergenic CYP1A1,CYP1A2 TSS1500 chr15:75018186-75019336 Island 4.33E-13 0.037564996 0.005082323
15 cg11924019 intergenic CYP1A1,CYP1A2 TSS1500 chr15:75018186-75019336 Island 6.07E-12 0.029699312 0.004240665
15 cg12101586 intergenic CYP1A1,CYP1A2 TSS1500 chr15:75018186-75019336 Island 6.16E-12 0.033228312 0.004745949
15 cg22549041 intergenic CYP1A1,CYP1A2 TSS1500 chr15:75018186-75019336 Island 1.02E-11 0.045041658 0.00650389
15 cg18092474 intergenic CYP1A1,CYP1A2 TSS1500 chr15:75018186-75019336 Island 2.95E-11 0.03943739 0.005831697
5 cg17924476 intronic AHRR Body chr5:320788-323010 S_Shore 1.16E-10 0.021888448 0.003342621
15 cg17852385 intergenic CYP1A1,CYP1A2 TSS1500 chr15:75018186-75019336 Island 2.05E-10 0.025807923 0.003996831
16 cg00253658 intergenic FTO, LOC100996338 4.50E-10 0.032150112 0.005079598
X cg04224247 intronic WWC3 5’UTR chrX:9982513-9984583 Island 9.01E-10 –0.029045508 0.004673566
5 cg05575921 intronic AHRR Body chr5:373842-374426 N_Shore 1.26E-09 –0.020194441 0.003278542
15 cg00213123 intergenic CYP1A1,CYP1A2 TSS1500 chr15:75018186-75019336 Island 5.06E-09 0.013568664 0.002291017
10 cg15507334 upstream FRMD4A TSS200 5.57E-09 0.023297316 0.003944714
7 cg15578140 ncRNA_intronic MIR548T Body 8.41E-09 0.017756893 0.003043603
5 cg01899089 intronic AHRR Body chr5:370185-370422 N_Shore 1.06E-08 –0.015519815 0.002679093
2 cg24935556 intergenic APOB, LOC645949       3.37E-08 –0.012281317 0.002198374
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EWAS of adolescent smoking did not detect any associations 
with CpG methylation levels at genome-wide significance p < 
1.06 × 10−7 (Supplemental Table S9). We performed a stratified 
analysis for adolescents who were smoking, but were not exposed 
to maternal smoking during pregnancy, versus those who were 
exposed. Comparison of the beta coefficients suggested a stronger 
effect of maternal smoking than of adolescent smoking; for the 
group of not exposed adolescent smokers, the beta coefficients 
were smaller than the ones for those exposed to maternal smoking, 
but none of the CpGs were significantly associated with adolescent 
smoking (Figure 3, Supplemental Tables S11 and S12).
Cardiometabolic Variables
Analyses that examined the methylation levels at the 23 
CpGs associated with maternal smoking and cardiometabolic 
risk factors in the entire study population and separately for 
male and female, showed methylation levels at two CpGs 
(cg00253568 and cg00213123, located in the FTO and CYP1A1 
region) significantly associated with TG (cg00253568, full study 
population; coefficient, 1.97; standard error, 0.63; Bonferroni 
p value, 0.041), diastolic blood pressure (cg00253568, female 
subset; coefficient, 3.06; standard error, 0.91; Bonferroni p 
value, 0.021), and HDL-C (cg00213123, male subset; coefficient, 
FIGURE 3 | Adolescent smoking, stratified by exposure to maternal smoking during pregnancy, and compared to the effect of maternal smoking during pregnancy 
(maternal smoking n = 790, adolescent smoking, maternal smoking n = 168, adolescent smoking, no maternal smoking n = 495). Models adjusted for sex, offspring 
age, age of the mother, birthweight, gestational weight gain, maternal alcohol consumption during pregnancy, maternal school level, maternal prepregnancy BMI, 
family income during pregnancy, cell count, and batch effects. X-axis: effect size from the linear mixed effects model and confidence interval; Y-axis: individual CpGs. 
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6.72; standard error, 2.04; Bonferroni p value, 0.025), whereas 
almost all of the 23 CpGs showed trends of either hyper- or 
hypomethylation in association with cardiometabolic variables, 
indicating a potentially long lasting effect of maternal smoking 
on cardiometabolic health of the offspring (Boxplots for 
cardiometabolic variables, stratified by exposure to maternal 
smoking: Supplemental Table S5).
Effect of SNPs on the Association Between CpG 
Methylation and Maternal Smoking
When adding the SNPs that were associated with the identified 23 
CpGs in this study to the main model, the significant association 
between CpG methylation and maternal smoking persisted 
(Supplemental Table S13). Furthermore, the SNPs were not 
significantly associated with exposure to maternal smoking 
during pregnancy. This means that the association between DNA 
methylation and maternal smoking during pregnancy seems to 
be independent of SNPs, highlighting the potential importance 
of environmental influences on DNA methylation.
DISCUSSION
In this study, we showed associations between in utero maternal 
smoking exposure and CpG methylation in whole-blood DNA 
from adolescents, independent of paternal smoking during 
the period of pregnancy, cumulative passive smoke exposure, 
and adolescent smoking. Additionally, we showed a trend for 
dose-dependent effects of maternal smoking on offspring CpG 
methylation levels. The CpG methylation level associations with 
maternal smoking are in accordance with previous findings 
at birth (Joubert et al., 2016), during childhood (Rzehak 
et al., 2016), adolescence (Lee et al., 2015), and in middle age 
(Sun et   al., 2013). Apart from cg24935556 (APOB), all CpGs 
identified in this study were identified in the meta-analysis by 
Joubert et al. (2016).
We did not detect associations between paternal smoking 
during pregnancy, adolescent smoking, or passive smoking 
exposure and DNA methylation. Our findings suggest that 
maternal smoking during pregnancy induces long-lasting DNA 
methylation changes in the offspring established by adolescence, 
which are not greatly modified by postnatal smoke exposure. 
Furthermore, we found that methylation levels at two CpGs 
(cg00253568 and cg00213123, located in the FTO and CYP1A1 
region) identified in association with maternal smoking during 
pregnancy were also associated with cardiometabolic health 
variables, suggesting that maternal smoking during pregnancy 
may induce changes that affect offspring cardiometabolic health.
Maternal Smoking
Differential hypermethylation associated with AHRR, 
CNTNAP2, CYP1A1, FRMD4A, GFI1, MYO1G, and CYP1A1 
has been shown previously in the same CpGs that we 
identified (Rotroff et al., 2016; Tehranifar et al., 2018). A 
study analyzing the associations between maternal smoking 
during pregnancy and adolescent CpG methylation levels in 
a discovery population of 132 and a replication cohort of n 
= 447 also showed methylation levels associated to maternal 
smoking within MYO1G, CNTANAP2, GFI1, CYP1A1, and 
AHRR but did not analyze the effect of any other sources of 
smoke exposure on CpG methylation levels (Lee et al., 2015). 
The majority of CpG sites in the meta-analysis by Joubert et 
al. (2016) were identified with the same direction of effect 
as in our study. Given Joubert et al. analyzed cord blood 
and our study used whole blood, these findings demonstrate 
consistent methylation patterns over different tissue types and 
time of sampling, which suggests lasting effects of maternal 
smoking during pregnancy on offspring DNA methylation. The 
specific methylation sites that we identified are consistent with 
previous reports in neonates (from cord blood) and middle-
age populations [whole blood, lymphocytes (mononuclear)] 
(Philibert et al., 2013; Zeilinger et al., 2013). This establishes 
a high consistency of DNA methylation markers related to 
maternal smoking during pregnancy. Such lifetime persistence 
and consistency are essential prerequisites for using DNA 
methylation as a valid biomarker for exposure and potentially 
a predictor for future adverse health outcomes. Therefore, this 
study fills the gap in the literature confirming stable changes in 
DNA methylation in adolescence.
Overall, the findings from our study suggest that methylation 
changes are induced in early life and persist into adolescence. 
Maternal smoking during pregnancy potentially exposes the 
fetus to cigarette-related chemicals and toxins leading to an early 
life “programming” effect that persists into adolescence and 
potentially affects long-term health.
Paternal Smoking Effects
There are fewer studies examining the effect of paternal than 
maternal smoking on offspring health, although prepregnancy 
exposure to paternal smoking is associated with a higher risk 
of leukemia, childhood cancers, and asthma in the offspring 
(Jenkins et al., 2017).
Analyses in the ALSPAC study suggested associations between 
paternal prepregnancy smoking and offspring BMI (Pembrey 
et al., 2005). In this study, 166 fathers were identified who started 
smoking before their offspring was aged 11 years. Compared to the 
nonsmoking fathers and fathers with later onset of smoking, the 
male offspring of fathers who commenced smoking before they 
were 11 years old had a higher BMI at 9 years of age. When tested 
in the Raine study with paternal smoking during pregnancy and 
BMI of the offspring at 16 years of age, a significant association 
(p = 0.008) was found after adjusting for age and sex.
In another study, Jenkins et al. used the Illumina 450K 
BeadChip to examine the effect of paternal cigarette smoking on 
sperm DNA methylation (Jenkins et al., 2017) in 78 male never 
smokers compared to 78 smokers. They showed that 141 CpG 
loci were differentially methylated in the sperm of smokers and 
suggested transgenerational inheritance. In our study, we did not 
find any effects of paternal prepregnancy smoking on offspring 
whole-blood DNA methylation, possibly due to our sample being 
insufficiently statistically powered. It is also possible that the 
effect of paternal smoking might be less prominent and too small 
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to detect given our sample size. However, the inability to detect 
associated CpG methylation at genome-wide significance, while 
being able to detect a large number of CpGs with methylation 
levels associated maternal smoking, suggests a dominant effect of 
maternal smoke exposure.
Adolescent Smoking
There are some studies that have consistently shown cross-
sectional associations of CpG methylation with current smoking 
in adults and adolescents. For example, the CpG cg05575921, 
mapped to AHRR in our study, has been associated with smoking 
in a recent study (Li et al., 2018). Similarly, a study that analyzed 
the effect of smoking on several timepoints and after smoking 
cessation (Wilson et al., 2017) showed that cg05575921 and five 
other CpGs related to AHRR associated with smoking. Another 
study by Lee et al. in a Korean population with a sample size 
of 100 (31 current, 30 former, and 39 never smoker) showed 
similar results, with the strongest association again being with 
cg05575921 (Lee et al., 2016).
A limitation of each of these studies that have examined the 
effect of adolescent smoking on DNA methylation is attributing 
the findings to current smoking without consideration of the 
possible effects of in utero exposure in the form of maternal 
smoking during pregnancy. This is very likely a complication, 
as offspring of maternal smokers are more likely to smoke 
themselves (Gilman et al., 2003; Rosemary et al., 2012). Within 
our study, 55% of adolescent smokers had mothers who smoked.
In the current study, we addressed this issue by running 
separate analyses for those adolescents who smoked themselves 
and were exposed to maternal smoking during pregnancy versus 
the ones who were not exposed. This showed that the beta 
coefficients in the adolescent smokers who were also exposed to 
maternal smoking were most similar to the CpGs associated with 
maternal smoking in our main analysis. Although the sample size 
is too small to show significant effects, this suggests a dominant 
effect of in utero smoke exposure. This tendency can be seen in 
Supplemental Figure 4, when comparing the methylation change 
between the study participants not exposed to any smoking, those 
smoking at 17 years, those exposed to maternal smoking during 
pregnancy, and those exposed to both types of smoking. In this 
barplot, the exposure to maternal smoking during pregnancy 
causes the majority of the methylation change, mostly equal to 
those exposed to maternal smoking and smoking themselves.
Passive Smoking
To our knowledge, there are no studies to date analyzing the 
effect of passive smoke exposure over the life course on DNA 
methylation, despite the evidence that passive smoking is 
associated with manifold diseases such as chronic obstructive 
pulmonary disease, wheeze, asthma, and food allergy, as well as 
cancer (Le-Ha et al., 2013; Saulyte et al., 2014; Vardavas et al., 
2016). A study in the Avon Longitudinal Study of Parents and 
Children analyzed passive smoke exposure as paternal smoking 
during pregnancy and mothers exposure to smoking of her father 
and mother but did not assess the offspring’ s postnatal passive 
smoke exposure (Richmond et al., 2018).
In our analysis, we did not detect associations between 
lifetime passive smoke exposure and CpG methylation in 
adolescence. The accuracy and reliability of measurement of 
passive exposure may be limited. However, validity is enhanced 
in the current study by repeated longitudinal measures, which 
act as internal validation and prospective collection of data. The 
consistent answering of the question on maternal and paternal 
smoking over eight follow-ups, rather than from a single time 
point, increases the likelihood of a valid measure.
Cardiometabolic Risk-Related Genes
We observed increased methylation, within the FTO gene 
(cg00253658; chr16:54210496), in the offspring of mothers 
who had smoked during pregnancy. Variants in this gene have 
previously been shown to associate with birthweight and the 
development of obesity and diabetes (Frayling et al., 2007) 
Their functional impact may be in modifying expression of 
the IRX3 and IRX5 genes, rather than FTO itself (Smemo 
et  al., 2014). Others have found hypermethylation in the 
region of this gene in relation to maternal smoking, in African 
American and Hispanic populations although in a different 
CpG, namely cg03687532 (chr16:54228358) (Tehranifar et al., 
2018). Furthermore, methylation levels are FTO, and CYP1A1 
mapped CpGs were significantly associated with TG, diastolic 
blood pressure and HDL-C in our study, suggesting correlation 
with early life environments (i.e., smoke exposure) and later 
cardiometabolic health.
Another study found that CpGs associated with exposure 
to maternal smoking during pregnancy were also associated 
with all cause as well as cardiovascular mortality. This study 
identified significant associations for all cause and cardiovascular 
specific mortality with the CpGs cg05575921 and cg06126421 
(Zhang et  al., 2016). In our study, cg05575921 was associated 
with maternal smoking during pregnancy but not significantly 
associated with any of the cardiometabolic risk factors. However, 
methylation levels at cg05575921 were associated with the lowest 
p value across the genome with systolic blood pressure in the male 
and female combined analysis (uncorrected p = 0.02, Bonferroni 
corrected = 0.47), the lowest p value in the female only association 
with systolic blood pressure (uncorrected p = 0.006, Bonferroni 
corrected = 0.14), among the top 5 lowest p values in the female 
only with diastolic blood pressure analysis (uncorrected p = 
0.017, Bonferroni corrected = 0.39), and methylation levels 
at this CpG with the second lowest p value in the female only 
analysis with TG (uncorrected p = 0.01, Bonferroni corrected = 
0.34). Considering the low sample sizes, especially of the female 
subset (n = 370), there may be a suggestive association.
The beforementioned study by Parmar et al. (2018) found a 
most significant association between CpG methylation levels and 
maternal prenatal smoking with waist circumference, TG, and 
blood pressure with cg14179389 (GFI1). As stated previously, 
this CpG was also among the 23 CpGs identified as having 
methylation levels significantly correlated with maternal smoking 
in our study, but methylation levels for cg14179389 were not 
significantly associated with cardiometabolic risk in our analysis. 
For the female subset in the TG analysis, however, methylation 
at this CpG had the lowest uncorrected p value (uncorrected 
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p = 0.01, Bonferroni corrected = 0.27). This sex-specific tendency 
seems to be in line with what Parmer et al. observed, as they 
stated that adjusting their model for sex, age, and adult own 
smoking strengthened the association. Furthermore, considering 
they found associations with a Bonferroni corrected p ≤ 0.01 
within a meta-analysis, accessing a sample size of 18,212 adults, 
our findings only showing tendencies with a maximum of n = 
870 is not surprising.
Strengths and Limitations
Strengths of this study are the prospective and repeated measures 
(at eight time points) of cigarette smoke exposure in ~800 
participants. The internal validation of cross-checking answers 
across time increases the reliability of the questionnaire data. 
Our findings accord with the same CpG sites that associate with 
smoking in studies that have used cotinine levels to confirm 
smoking status (Joubert et al., 2012; Philibert et al., 2013; Lee 
et al., 2016; Morales et al., 2016; Rotroff et al., 2016). DNA 
methylation sites identified in our study are in gene regions 
previously associated with maternal smoking and are in the same 
direction of association (Joubert et al., 2016).
While cotinine is considered the gold standard for evaluation 
of smoking, a number of studies have shown very high 
correlations between cotinine levels and questionnaire data, up 
to 97% (Patrick et al., 1994; Parazzini et al., 1996; Vartiainen 
et al., 2002; Dolcini et al., 2003). A subset of the Raine study 
mothers (n = 238) had cotinine measures available at 28 weeks 
of gestation, and, as previously shown, cotinine concentration 
significantly differed between the groups of reported number of 
cigarettes smoked, highlighting the validity of the Raine study 
maternal smoking questionnaire data (Stick et al., 1996).
A further strength of our study is the ability to adjust for a 
wide range of possible confounders, in particular socioeconomic 
status, which is associated with smoking behavior and DNA 
methylation (McDade et al., 2019). However, it is still possible 
that other unmeasured environmental factors in pregnancy 
or postnatally could be influencing or modifying some of 
these findings. Owing to the deeply phenotyped character 
of the Raine study, we were able to adjust all the models for 
multiple sources of smoke exposure, narrowing down to the 
specific effect of maternal smoking on DNA methylation in 
the offspring. The fact that we found associations between 
methylation levels at the identified CpGs and cardiometabolic 
health-related variables suggests correlations between smoke 
exposure and offspring health.
A further strength of our study is that we integrated genetic 
(SNPs) and epigenetic (CpG methylation) information and 
assessed if the association between CpG methylation and maternal 
smoking during pregnancy still persists when accounting for 
SNPs. To our knowledge, this was not done to this extent in any 
DNA methylation wide association study previous to ours.
The majority of CpG sites in the meta-analysis by Joubert et al. 
(2016) were identified with the same direction of effect as in our 
study. Given that Joubert et al. analyzed cord blood and our study 
used whole blood, these findings demonstrate consistent DNA 
methylation patterns over different sample types and time points 
in response to maternal smoking during pregnancy.
A potential limitation is that we only examined methylation 
from whole-blood DNA, which might not be the site of change in 
association with smoking. Few population studies have cell-sorted 
DNA methylation, and our findings suggest that some of these 
changes may be induced across multiple cell types. Furthermore, 
the sample sizes of some of the analysis that we conducted are 
below 200, making them potentially underpowered to detect 
small epigenetic changes.
It is known that up to 6% of the probes in the Illumina 
Methylation450 BeadChip kit could give false positives, due to 
known cross-reactivity. Furthermore, the array only covers 2% 
of the epigenome CpG DNA methylation sites (Kurdyukov and 
Bullock, 2016). To mitigate some of these limitations, we performed 
thorough preprocessing and QC steps to remove any problematic 
probes and samples. In addition, we accounted for batch effects 
in all our models and used a conservative Bonferroni correction 
for multiple testing to minimize any false positives that may have 
arisen due to technical issues from probes on the 450k array.
In our cohort, it is encouraging that we show similar 
associations between in utero smoke exposure and CpG 
methylation, both in amount and specific sites (Breton et al., 2017). 
However, performing independent methylation analysis such as 
pyrosequencing would have further strengthened the inferences. 
Lastly, for the dose–response relationship, the questionnaire 
variable for the number of cigarettes consumed needs to be 
analyzed with caution. With questionnaire data, there is always a 
chance of recall bias or underreporting, especially when it comes 
to behaviors such as cigarette or alcohol consumption.
CONCLUSIONS
We have shown associations between maternal smoking 
during pregnancy and offspring DNA methylation at 23 
CpGs in adolescents at age 17 years. These associations were 
predominantly driven by maternal smoking and not modified 
by paternal, passive, or adolescent smoking. Furthermore, we 
are unable to detect genome-wide significant associations with 
paternal smoking and passive smoke exposure at any CpG sites. 
Our data that suggest DNA methylation changes in offspring 
are likely due to the direct effect of maternal smoking during 
pregnancy, rather than current, passive, or paternal smoking. 
Future studies on smoking habits and DNA methylation should 
adjust for maternal smoking, in addition to socioeconomic 
status of the mother and/or offspring, depending on the age of 
the offspring. The specific methylation sites that we identified 
are in agreement with previous reports in neonates (from cord 
blood) and middle aged populations [whole blood, lymphocytes 
(mononuclear)] (Philibert et al., 2013; Zeilinger et al., 2013). 
This establishes a high consistency of DNA methylation markers 
related to maternal smoking during pregnancy. Such persistence 
and consistency are essential prerequisites for using DNA 
methylation as a valid biomarker for exposure and potentially a 
predictor for future adverse health outcomes. Furthermore, we 
showed that maternal-smoking-induced methylation changes 
are associated with cardiometabolic variables, suggesting early 
life “programming” of later life cardiometabolic health.
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